Exclusive look at our Italian contribution to The Life Sciences Law Review

The fourth edition of The Life Sciences Review was recently published which included valued contributions made by our IP and Life Sciences group in Italy.

Our chapter provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in the Italian market. It contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business.

The resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.

Please click here for the PDF version of the exclusive Italy chapter. If you would like to view the eBook or PDF version of the entire Life Sciences Law Review, please click on the image.

News & Deals

More News & Deals
Deal Bird & Bird advises ECBF on Series A financing round in Vegdog

Sep 16 2025

Read More
Deal Bird & Bird advises the University of Hong Kong on the acquisition of a building in Barcelona for its first educational project in Europe

Sep 16 2025

Read More
News Bird & Bird appoints Chris Case as partner in Australia

Sep 16 2025

Read More
Deal Bird & Bird advises Kingyue International and Evolve Capital on Mandatory Unconditional Cash Offer for Samko Timber

Sep 15 2025

Read More
News Bird & Bird appoints energy expert Jenny Murray as new partner

Sep 15 2025

Read More
News Bird & Bird strengthens disputes capability in Life Sciences with French partner appointment

Sep 15 2025

Read More

Related capabilities